TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments

MabVax Therapeutics Holdings, Inc. (NASDAQ:MBVX) Investor Investigation Over Possible Violations Of Securities Laws Announced

  • If you purchased shares of MabVax Therapeutics Holdings, Inc. (NASDAQ:MBVX), you have certain options and you should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this investigation, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Investigation Overview

Company
MabVax Therapeutics Holdings, Inc.
Security
NASDAQ: MBVX

Summary

An investigation on behalf of investors of MabVax Therapeutics Holdings, Inc. (NASDAQ:MBVX) shares over potential securities laws violations by MabVax Therapeutics Holdings, Inc. and certain of its directors and officers in connection with certain financial statements was announced.

The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of MabVax Therapeutics Holdings, Inc. (NASDAQ:MBVX) concerning whether a series of statements by MabVax Therapeutics Holdings, Inc. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

San Diego, CA based MabVax Therapeutics Holdings, Inc. is a clinical-stage biotechnology company with a fully human antibody discovery platform.

On January 30, 2018, MabVax Therapeutics Holdings, Inc. announced that it received notice that the Securities and Exchange Commission (SEC) was conducting an investigation and examination pursuant to Section 8(e) of the Securities Act of 1933, as amended, relating to certain of the Companys registration statements (and amendments thereto).

Start Monitoring Your Investments